Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 451–500 of 771 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05484375	Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment	not yet recruiting	Phase 2	40	Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER	0	Aug 2, 2022	clinicaltrials
NCT04001413	Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients	withdrawn	Phase 2	0	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1